These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16918095)

  • 1. Cancer-related breakthrough pain.
    Davies AN
    Br J Hosp Med (Lond); 2006 Aug; 67(8):414-6. PubMed ID: 16918095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl buccal tablet (Fentora) for breakthrough pain.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):78-9. PubMed ID: 17878889
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioids for management of breakthrough pain in cancer patients.
    Potter MB
    Am Fam Physician; 2006 Dec; 74(11):1855-7. PubMed ID: 17168339
    [No Abstract]   [Full Text] [Related]  

  • 4. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
    Rhiner M; Palos G; Termini M
    Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl nasal spray (Lazanda) for pain.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oral transmucosal fetanyl citrate in the management of breakthrough cancer pain.
    Rees E
    Int J Palliat Nurs; 2002 Jun; 8(6):304-8. PubMed ID: 12131825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
    Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE; Xie F; Messina J; Segal TJ
    J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fentanyl in cancer-related pain.
    Prommer E
    J Palliat Med; 2009 Oct; 12(10):947-54. PubMed ID: 19807240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
    Fine PG; Narayana A; Passik SD
    Pain Med; 2010 Jul; 11(7):1024-36. PubMed ID: 20642730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new transmucosal fentanyl for breakthrough cancer pain.
    Rospond RM
    Cancer Pract; 1999; 7(6):317-20. PubMed ID: 10732531
    [No Abstract]   [Full Text] [Related]  

  • 14. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM; Messina J; Xie F
    Cancer; 2009 Jun; 115(11):2571-9. PubMed ID: 19373888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated strategies for the successful management of breakthrough cancer pain.
    Dickman A
    Curr Opin Support Palliat Care; 2011 Mar; 5(1):8-14. PubMed ID: 21325998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain.
    Farrar JT; Messina J; Xie F; Portenoy RK
    Pain Med; 2010 Sep; 11(9):1313-27. PubMed ID: 20807345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of breakthrough cancer pain].
    Sláma O
    Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
    Gordon DB
    Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.
    Zeppetella G
    Palliat Med; 2000 Jan; 14(1):57-8. PubMed ID: 10717724
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of oral formulations of fentanyl for breakthrough cancer pain.
    Handsaker S; Dempsey L; Fabby C
    Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.